Bayer and Charitè Launch Cutting-Edge Biotech Center in Berlin

Publish Date:  July 18th, 2024

Berlin is set to become a leading hub for gene and cell therapies (CGTs) with the launch of a groundbreaking new center. The Berlin Center for Gene and Cell Therapies, a joint initiative by Bayer AG and Charité – Universitätsmedizin Berlin, has received substantial support from the German government, including €80 million from the Federal Ministry of Education and Research. More information here.